Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer

Lung Cancer

Volumn 60, Issue 2, 2008, Pages 175-182

  Zhang, Xiaozhu ^a   Zhao, Yi ^b   Wang, Miao ^a   Yap, Wee See ^c   Chang, Alex Yuang chi ^a  

^a Johns Hopkins Singapore   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

EGFR mutation; Malignant pleural effusion; Mutant enriched PCR; NSCLC; Sequencing

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MUTATIONAL ANALYSIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; PLEURAL EFFUSION, MALIGNANT; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 42949122533     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.10.011     Document Type: Article

References (24)

1. Miller J.D., Gorenstein L.A., and Patterson G.A. Staging: the key to rational management of lung cancer. Ann Thorac Surg 53 1 (1992) 170-178
2. Fukuoka M., Yano S., Giaccone G., Tamura T., Nakagawa K., Douillard J.Y., et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol 21 12 (2003) 2237-2246
3. Kris M.G., Natale R.B., Herbst R.S., Lynch Jr. T.J., Prager D., Belani C.P., et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. Jama 290 16 (2003) 2149-2158
4. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 5676 (2004) 1497-1500
5. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 21 (2004) 2129-2139
6. Antony V.B., Loddenkemper R., Astoul P., Boutin C., Goldstraw P., Hott J., et al. Management of malignant pleural effusions. Eur Respir J 18 2 (2001) 402-419
7. Canto A., Ferrer G., Romagosa V., Moya J., and Bernat R. Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic locations. Chest 87 5 (1985) 649-652
8. Benlloch S., Galbis-Caravajal J.M., Martin C., Sanchez-Paya J., Rodriguez-Paniagua J.M., Romero S., et al. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer 107 8 (2006) 1859-1865
9. Nakamoto M., Teramoto H., Matsumoto S., Igishi T., and Shimizu E. K-ras and rho A mutations in malignant pleural effusion. Int J Oncol 19 5 (2001) 971-976
10. Lee J.H., Hong Y.S., Ryu J.S., and Chang J.H. p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion. Lung Cancer 44 1 (2004) 33-42
11. Kimura H., Fujiwara Y., Sone T., Kunitoh H., Tamura T., Kasahara K., et al. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Br J Cancer 95 10 (2006) 1390-1395
12. Huang M.J., Lim K.H., Tzen C.Y., Hsu H.S., Yen Y., and Huang B.S. EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report. Lung Cancer 49 3 (2005) 413-415
13. Kimura H., Fujiwara Y., Sone T., Kunitoh H., Tamura T., Kasahara K., et al. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients. Cancer Sci 97 7 (2006) 642-648
14. Soh J., Toyooka S., Aoe K., Asano H., Ichihara S., Katayama H., et al. Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. Int J Cancer 119 10 (2006) 2353-2358
15. Asano H., Toyooka S., Tokumo M., Ichimura K., Aoe K., Ito S., et al. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 12 1 (2006) 43-48
16. Zhang X., and Chang A. Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer. J Med Genet 44 3 (2007) 166-172
17. Meyer P.C. Metastatic carcinoma of the pleura. Thorax 21 5 (1966) 437-443
18. Chernow B., and Sahn S.A. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63 5 (1977) 695-702
19. Fan X., Furnari F.B., Cavenee W.K., and Castresana J.S. Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells. Int J Oncol 18 5 (2001) 1023-1026
20. Endo K., Konishi A., Sasaki H., Takada M., Tanaka H., Okumura M., et al. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50 3 (2005) 375-384
21. Marchetti A., Martella C., Felicioni L., Barassi F., Salvatore S., Chella A., et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 23 4 (2005) 857-865
22. Nagai Y., Miyazawa H., Huqun, Tanaka T., Udagawa K., Kato M., et al. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 65 16 (2005) 7276-7282
23. Toyooka S., Tsukuda K., Ouchida M., Tanino M., Inaki Y., Kobayashi K., et al. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR. Oncol Rep 10 5 (2003) 1455-1459
24. Kahn S.M., Jiang W., Culbertson T.A., Weinstein I.B., Williams G.M., Tomita N., et al. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene 6 6 (1991) 1079-1083